GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Templeton Global Income Fund (NYSE:SABA) » Definitions » EPS without NRI
中文

Templeton Globalome Fund (Templeton Globalome Fund) EPS without NRI

: $0.18 (TTM As of Jun. 2023)
View and export this data going back to . Start your Free Trial

Templeton Globalome Fund's earnings per share without non-recurring items for the six months ended in Jun. 2023 was $0.07. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was $0.18.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Templeton Globalome Fund's EPS without NRI or its related term are showing as below:

SABA's 3-Year EPS without NRI Growth Rate is not ranked *
in the Asset Management industry.
Industry Median: 7.9
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Templeton Globalome Fund's EPS (Diluted) for the six months ended in Jun. 2023 was $0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.18.

Templeton Globalome Fund's EPS (Basic) for the six months ended in Jun. 2023 was $0.07. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.18.


Templeton Globalome Fund EPS without NRI Historical Data

The historical data trend for Templeton Globalome Fund's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Templeton Globalome Fund Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21
EPS without NRI
0.20 0.14 0.12 -0.42 -0.30

Templeton Globalome Fund Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.22 -0.50 0.11 0.07

Competitive Comparison

For the Asset Management subindustry, Templeton Globalome Fund's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Templeton Globalome Fund PE Ratio without NRI Distribution

For the Asset Management industry and Financial Services sector, Templeton Globalome Fund's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Templeton Globalome Fund's PE Ratio without NRI falls into.



Templeton Globalome Fund EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Templeton Globalome Fund  (NYSE:SABA) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Templeton Globalome Fund EPS without NRI Related Terms

Thank you for viewing the detailed overview of Templeton Globalome Fund's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Templeton Globalome Fund (Templeton Globalome Fund) Business Description

Traded in Other Exchanges
N/A
Address
300 S.E. 2nd Street, Fort Lauderdale, FL, USA, 33301-1923
Templeton Global Income Fund is a closed-end fund. It seeks high current income, with a secondary goal of capital appreciation. Under normal market conditions. The Fund invests at least over 80% of its net assets in income-producing securities, including debt securities of the United States and foreign issuers, including emerging markets.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Oliveira Marc De officer: VP & Secretary C/O LEGG MASON & CO. LLC, ONE FIRST STAMFORD PLACE, STAMFORD CT 06902
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Ted P Becker officer: Chief Compliance Officer 399 PARK AVENUE, 4TH FLOOR, NEW YORK NY 10022
George P. Hoyt officer: VP & Secretary C/O FRANKLIN TEMPLETON, 100 FIRST STAMFORD PLACE, STAMFORD CT 06902
Garry Khasidy director 131 MUNSTER ROAD, LONDON X0 SW6 6DD
Mark Hammitt director 8 THE GREEN, SUITE 10664, DOVER DE 19901
Karen Caldwell director 10125 SOUTH BELL AVENUE, CHICAGO IL 60643
Ketu Desai director 999 RIVERVIEW DR, SUITE 201, TOTOWA NJ 07512
Anatoly Nakum director 52 EAST END AVENUE, APT. 18, NEW YORK NY 10028
Franklin Resources Inc other: Affiliate of Investment Adv. FRANKLIN RESOURCES INC, ONE FRANKLIN PARKWAY, SAN MATEO CA 94403
Christopher Kings officer: CFO, CAO and Treasurer ONE FRANKLIN PARKWAY, SAN MATEO CA 94403
Ryan Wheeler officer: Interim CFO, CAO and Treasurer 300 S.E. 2ND STREET, FORT LAUDERDALE FL 33301
Susan Kerr officer: VP - AML Compliance 280 PARK AVENUE, NEW YORK NY 10017
Paul Charles Kazarian director C/O SABA CAPITAL MANAGEMENT, L.P., 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174